Ageing with cystic fibrosis: Challenges ahead
Sacha Spelier1, Maud I M van der Wijst1, Isabelle Fajac2
1Department of Pediatric Respiratory Medicine, Wilhelmina Children's Hospital, University Medical Center, Utrecht University, Utrecht, the Netherlands; Regenerative Medicine Utrecht, University Medical Center, Utrecht University, Utrecht, the Netherlands.
Summary
Improved care for cystic fibrosis (CF) increases life expectancy, leading to new challenges like age-related diseases. Research is exploring how aging and CF interact to impact long-term health.
Area of Science:
- Pulmonology and Respiratory Medicine
- Gerontology and Aging Research
- Medical Genetics
Background:
- Improving life expectancy in cystic fibrosis (CF) patients presents new clinical challenges.
- Age-related comorbidities are becoming increasingly prevalent in the aging CF population.
- CFTR modulator therapies have significantly advanced CF care.
Purpose of the Study:
- To review insights on aging and CF from the 20th ECFS Basic Science Conference.
- To outline mechanisms of aging in the context of CF disease.
- To highlight age-associated comorbidities in CF and suggest future research directions.
Main Methods:
- Review of symposium insights on aging and CF.
- Outline of aging mechanisms relevant to CF.
- Identification and discussion of key age-associated comorbidities in CF.
Main Results:
- Aging mechanisms intersect with CF disease processes.
- Cardiovascular disease and colorectal cancer are significant age-associated comorbidities in CF.
- Understanding the interplay between CF and general aging is crucial.
Conclusions:
- Long-term care strategies for aging CF populations require understanding CF-specific and general aging mechanisms.
- Further research is needed to clarify the intersection of aging and CF.
- Addressing age-related comorbidities is essential for improving outcomes in the growing CF population.
More Related Videos
Related Concept Videos
01:24Cystic Fibrosis: Management
465
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
465
01:23Cystic Fibrosis: Pathogenesis
703
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
703
01:19The Effect of Aging on Tissues
3.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K